New Jersey A 3290: Prohibits substitution of prescribed epilepsy medication without notification and written consent of physician and patient; requires prescription to include notation of epilepsy diagnosis.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-02-25)

State: New Jersey · Session: 219 · Bill: A 3290

Subjects: HUMAN SVCS, PHARMACEUTIC

Sponsors: Vainieri Huttle, Valerie

View New Jersey A 3290 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.